Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2750 of 3546 entries
View as:

Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00240565 Org: User:
Start: 04/30/04 End: 09/30/11 Due: 09/30/12

Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

Phase: N/A Priority: Normal
NCT ID: NCT02292784 Org: User:
Start: 06/01/15 End: 09/02/19 Due: 09/02/20

A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT02415842 Org: User:
Start: 10/26/15 End: 02/16/18 Due: 02/16/19

Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder

Phase: N/A Priority: Normal
NCT ID: NCT01847430 Org: User:
Start: 07/19/13 End: 02/21/14 Due: 02/21/15

Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database

Phase: N/A Priority: Normal
NCT ID: NCT01381510 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

MDD POC Study GSK372475 Subjects Depressive Disease

Phase: N/A Priority: Normal
NCT ID: NCT00420641 Org: User:
Start: 12/19/06 End: 10/15/08 Due: 10/15/09

Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT00593593 Org: User:
Start: 12/31/04 End: - Due: -

Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A

Phase: N/A Priority: Normal
NCT ID: NCT00540592 Org: User:
Start: 10/08/07 End: 06/10/08 Due: 06/10/09

Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate

Phase: N/A Priority: Normal
NCT ID: NCT00400855 Org: User:
Start: 01/31/05 End: 08/31/05 Due: 08/31/06

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3

Phase: N/A Priority: Normal
NCT ID: NCT06926673 Org: User:
Start: 12/23/21 End: 05/02/24 Due: 05/02/25

A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06702462 Org: User:
Start: 03/18/25 End: 05/29/25 Due: 05/29/26

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06887933 Org: User:
Start: 04/22/25 End: 07/08/26 Due: 07/08/27

A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants

Phase: N/A Priority: Normal
NCT ID: NCT06331156 Org: User:
Start: 03/22/24 End: 10/22/24 Due: 10/22/25

Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT00456625 Org: User:
Start: 04/30/07 End: 01/31/08 Due: 01/31/09

A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00363142 Org: User:
Start: 05/31/06 End: 06/30/08 Due: 06/30/09

Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00903422 Org: User:
Start: 05/14/09 End: 12/05/13 Due: 12/05/14

Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR

Phase: N/A Priority: Normal
NCT ID: NCT00412191 Org: User:
Start: 02/06/07 End: 04/27/07 Due: 04/27/08

A Human Volunteer Study Investigating Single Oral Doses of GSK598809 in Otherwise Healthy Smokers

Phase: N/A Priority: Normal
NCT ID: NCT00728052 Org: User:
Start: 06/09/08 End: 08/19/08 Due: 08/19/09

A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00504439 Org: User:
Start: 06/04/07 End: 09/06/07 Due: 09/06/08

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

Phase: N/A Priority: Normal
NCT ID: NCT00310375 Org: User:
Start: 05/01/06 End: 03/15/17 Due: 03/15/18

Provoked Craving Assessment

Phase: N/A Priority: Normal
NCT ID: NCT01506908 Org: User:
Start: 09/30/11 End: 12/31/11 Due: 12/31/12

The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population

Phase: N/A Priority: Normal
NCT ID: NCT02119325 Org: User:
Start: 09/30/13 End: - Due: -

Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT01916200 Org: User:
Start: 01/31/14 End: 09/30/14 Due: 09/30/15

A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00048204 Org: User:
Start: 11/04/02 End: 09/30/03 Due: 09/30/04

Study Of Allergic Rhinitis In Patients Who Also Have Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00296491 Org: User:
Start: 09/30/05 End: 10/31/07 Due: 10/31/08